7 резултати
FIELD OF THE INVENTION
The invention relates generally to methods and compositions for the treatment of cancer. In particular, diindolylmethane, ring substituted diindolylmethane, C-substituted diindolylmethane, and analogs thereof that possess potent antiestrogenic and antitumorigenic activities
FIELD OF THE INVENTION
The invention relates generally to methods and compositions for the treatment of cancer. In particular, diindolylmethane, ring substituted diindolylmethane, C-substituted diindolylmethane, and analogs thereof that possess potent antiestrogenic and antitumorigenic activities
FIELD OF THE INVENTION
The invention relates generally to methods and compositions for the treatment of cancer. In particular, diindolylmethane, ring substituted diindolylmethane, C-substituted diindolylmethane, and analogs thereof that possess potent antiestrogenic and antitumorigenic activities
I. FIELD OF THE INVENTION
This invention relates to the treatment of cervical or vaginal neoplasia including cervical intraepithelial neoplasia ("CIN"), intraepithelial neoplasia, vulvar intraepithelial neoplasia and ano-genital warts, and in particular, provides a method of treatment to prevent
FIELD OF THE INVENTION
The invention relates generally to methods and compositions for the treatment of cancer. In particular, diindolylmethane, ring substituted diindolylmethane, C-substituted diindolylmethane, and analogs thereof that possess potent antiestrogenic and antitumorigenic activities
CROSS REFERENCE TO RELATED APPLICATIONS
This application is the National Stage of PCT/RU2013/000568 filed on Jul. 19, 2013, which claims priority under 35 U.S.C. .sctn.119 of Russian Application No. 2012144002 filed on Oct. 16, 2012, the disclosures of which are incorporated by reference. The
BACKGROUND
Radioprotector agents are used in diagnostic and therapeutic settings to protect normal (e.g., non-cancerous) tissues or structures from radiation damage. These agents are also used as a means of protection in the setting of radiation exposure to the normal population. However, current